#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Squamous cell carcinoma of the hypopharynx Frostbite Henoch-Schonlein purpura nephritis Leukocyte adhesion deficiency type I Barth syndrome Hepato-lenticular degeneration Ewing's sarcoma metastatic Methylmalonic acidaemia Astrocytoma Cholestatic pruritus Huntington's disease Paraneoplastic neurological syndrome Gaucher's disease type III Progressive supranuclear palsy Neurotrophic keratopathy More trials…
Learn about Rare Diseases

Wiskott-Aldrich syndrome Lymphangioma – Treatment Factor VIII deficiency – Treatment Primary hyperoxaluria – Diagnostics Prader-Willi syndrome Haemophilia A without inhibitors – Trials in Disease Mucopolysaccharidosis II – Life with Disease IgA nephropathy – Trials in Disease VEXAS syndrome – Trials in Disease Prader-Willi syndrome – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Poltreg-T1D Colesevelam Oteracil Water For Injections Specific Nucleic Acid Sna-Xfsc Cx-037231 Ddcart‐Cd19 COLESEVELAM HYDROCHLORIDE Surzebiclimab Pariglasgene Brecaparvovec Selgantolimod Voclosporin GRISNILIMAB SETARITOX Buclizine Hydrochloride Belzutifan Tipapkinogene Sovacivec Etoposide Aminocaproic Acid Idarubicin Folinic Acid More therapies…

Learn about Your Condition

Large cell lung cancer stage 0 Small cell carcinoma Allergic respiratory disease Red blood cell abnormality Labour pain Neonatal asphyxia Drug eruption Spinal cord injury cervical Sickle cell anaemia Mixed dementia Peripheral spondyloarthritis Acarodermatitis Seizure Short-bowel syndrome Hypochromic anaemia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Precursor B-lymphoblastic lymphoma recurrent

Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ruxolitinib
- Venetoclax
+5
Study on Trametinib, Dexamethasone, Cyclophosphamide, and Cytarabine for Children with Relapsed or Refractory Blood Cancer

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Trametinib
+5
Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Dasatinib
- Venetoclax
+5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Precursor B-lymphoblastic lymphoma recurrent

Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

Study on Trametinib, Dexamethasone, Cyclophosphamide, and Cytarabine for Children with Relapsed or Refractory Blood Cancer

Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies